Erica M. Bednar

Erica M. Bednar

Auto-generated profile, based on publicly available information

Erica M. Bednar

Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Health Affairs
Verified
Journal Article
Closed access
MRMegan Roberts
Megan Roberts
WDW. David Dotson
W. David Dotson
CDChristopher S. DeVore
Christopher S. DeVore
EBErica M. Bednar
Erica M. Bednar
DBDeborah J. Bowen
Deborah J. Bowen
HHHeather Hampel
Heather Hampel
Cascade screening is the process of contacting relatives of people who have been diagnosed with certain hereditary conditions. Its purpose is to identify, inform, and manage those who are also at risk. We conducted a scoping review to obtain a broad overview of cascade screening interventions, facilitators and barriers to their use, relevant policy considerations, and future research needs. We searched for relevant peer-reviewed literature in the period 1990–2017 and reviewed 122 studies. Finally, we described 45 statutes and regulations related to the use and release of genetic information across the fifty states. We sought standardized best practices for optimizing cascade screening across various geographic and policy contexts, but we found none. Studies in which trained providers contacted relatives directly, rather than through probands (index patients), showed greater cascade screening uptake; however, policies in some states might limit this approach. Major barriers to cascade screening delivery include suboptimal communication between the proband and family and geographic barriers to obtaining genetic services. Few US studies examined interventions for cascade screening or used rigorous study designs such as randomized controlled trials. Moving forward, there remains an urgent need to conduct rigorous intervention studies on cascade screening in diverse US populations, while accounting for state policy considerations.

1 April 2019 in Gynecologic Oncology
Verified
Journal Article
Closed access
EHEmily M. Hinchcliff
Emily M. Hinchcliff
EBErica M. Bednar
Erica M. Bednar
KLKaren H. Lu
Karen H. Lu
JRJ. Alejandro Rauh-Hain
J. Alejandro Rauh-Hain

1 August 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
EBErica M. Bednar
Erica M. Bednar
HOHolly D. Oakley
Holly D. Oakley
CSCharlotte C. Sun
Charlotte C. Sun
CBCatherine C. Burke
Catherine C. Burke
MMMark F. Munsell
Mark F. Munsell
KLKaren Lu
Karen Lu

20 December 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
EBErica M. Bednar
Erica M. Bednar
CSCharlotte C. Sun
Charlotte C. Sun
SMSheryl McCurdy
Sheryl McCurdy
SVSally W. Vernon
Sally W. Vernon

7 April 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
EBErica M. Bednar
Erica M. Bednar
RNRoni Nitecki
Roni Nitecki
KKKate J. Krause
Kate J. Krause
JRJose Alejandro Rauh-Hain
Jose Alejandro Rauh-Hain

16 May 2018 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
EBErica M. Bednar
Erica M. Bednar
MWMichael T. Walsh
Michael T. Walsh
EBEllen Baker
Ellen Baker
KMKimberly I. Muse
Kimberly I. Muse
HOHolly D. Oakley
Holly D. Oakley
KLKaren H. Lu
Karen H. Lu